In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems B Semete, L Booysen, Y Lemmer, L Kalombo, L Katata, J Verschoor, ... Nanomedicine: Nanotechnology, Biology and Medicine 6 (5), 662-671, 2010 | 491 | 2010 |
Blood ketone bodies and breath acetone analysis and their correlations in type 2 diabetes mellitus V Saasa, M Beukes, Y Lemmer, B Mwakikunga Diagnostics 9 (4), 224, 2019 | 86 | 2019 |
Mycolic acids, a promising mycobacterial ligand for targeting of nanoencapsulated drugs in tuberculosis Y Lemmer, L Kalombo, RD Pietersen, AT Jones, B Semete-Makokotlela, ... Journal of controlled release 211, 94-104, 2015 | 57 | 2015 |
Cholesteroid nature of free mycolic acids from M. tuberculosis Y Benadie, M Deysel, DGR Siko, VV Roberts, S Van Wyngaardt, ... Chemistry and physics of lipids 152 (2), 95-103, 2008 | 55 | 2008 |
Structure–function relationships of the antigenicity of mycolic acids in tuberculosis patients M Beukes, Y Lemmer, M Deysel, R Juma’a, MS Baird, G Koza, ... Chemistry and physics of lipids 163 (8), 800-808, 2010 | 45 | 2010 |
Polylactide-based magnetic spheres as efficient carriers for anticancer drug delivery N Mhlanga, S Sinha Ray, Y Lemmer, J Wesley-Smith ACS applied materials & interfaces 7 (40), 22692-22701, 2015 | 39 | 2015 |
State of the art and future directions in nanomedicine for tuberculosis A Dube, Y Lemmer, R Hayeshi, M Balogun, P Labuschagne, H Swai, ... Expert Opinion on Drug Delivery 10 (12), 1725-1734, 2013 | 38 | 2013 |
Detection of antimycolic acid antibodies by liposomal biosensors Y Lemmer, ST Thanyani, PJ Vrey, CHS Driver, L Venter, S Van Wyngaardt, ... Methods in enzymology 464, 79-104, 2009 | 35 | 2009 |
Spray-dried, nanoencapsulated, multi-drug anti-tuberculosis therapy aimed at once weekly administration for the duration of treatment L Kalombo, Y Lemmer, B Semete-Makokotlela, B Ramalapa, P Nkuna, ... Nanomaterials 9 (8), 1167, 2019 | 26 | 2019 |
The hierarchical nanostructured Co-doped WO3/carbon and their improved acetone sensing perfomance V Saasa, T Malwela, Y Lemmer, M Beukes, B Mwakikunga Materials Science in Semiconductor Processing 117, 105157, 2020 | 24 | 2020 |
Effect of varying ethanol and water compositions on the acetone sensing properties of WO3 for application in diabetes mellitus monitoring V Saasa, Y Lemmer, T Malwela, A Akande, M Beukes, B Mwakikunga Materials Research Express 7 (3), 035905, 2020 | 18 | 2020 |
Polyethylene glycol–gum acacia-based multidrug delivery system for controlled delivery of anticancer drugs VO Fasiku, BA Aderibigbe, ER Sadiku, Y Lemmer, SJ Owonubi, SS Ray, ... Polymer bulletin 76, 5011-5037, 2019 | 18 | 2019 |
Standardization of natural mycolic acid antigen composition and production for use in biomarker antibody detection to diagnose active tuberculosis FL Ndlandla, V Ejoh, AC Stoltz, B Naicker, AD Cromarty, S van Wyngaardt, ... Journal of Immunological Methods 435, 50-59, 2016 | 17 | 2016 |
Synthesis, characterization and in vitro cytotoxicity evaluation of polyamidoamine conjugate containing pamidronate and platinum drug AS Ndamase, BA Aderibigbe, ER Sadiku, P Labuschagne, Y Lemmer, ... Journal of Drug Delivery Science and Technology 43, 267-273, 2018 | 10 | 2018 |
Potential of improving the treatment of tuberculosis through nanomedicine B Semete, L Kalombo, L Katata, P Chelule, L Booysen, Y Lemmer, ... Molecular Crystals and Liquid Crystals 556 (1), 317-330, 2012 | 8 | 2012 |
The antigenicity and cholesteroid nature of mycolic acids determined by recombinant chicken antibodies H Ranchod, F Ndlandla, Y Lemmer, M Beukes, J Niebuhr, J Al-Dulayymi, ... Plos one 13 (8), e0200298, 2018 | 6 | 2018 |
A model of isoniazid treatment of tuberculosis Y Lemmer, A Grobler, C Moody, H Viljoen Journal of Theoretical Biology 363, 367-373, 2014 | 6 | 2014 |
Immunogenicity of adjuvanted plant-produced SARS-CoV-2 Beta spike VLP vaccine in New Zealand white rabbits MM O'Kennedy, C Abolnik, T Smith, T Motlou, K Goosen, KM Sepotokele, ... Vaccine 41 (13), 2261-2269, 2023 | 5 | 2023 |
Amphotericin B as a mycolic acid specific targeting agent in tuberculosis Y Benadie PQDT-Global, 2006 | 5 | 2006 |
Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR-/-mice MM O'Kennedy, P Coetzee, O Koekemoer, L Du Plessis, CW Lourens, ... Vaccine 40 (35), 5160-5169, 2022 | 4 | 2022 |